Lv3
340 积分 2022-10-11 加入
Targeting inflammation to treat diabetic kidney disease: the road to 2030
8天前
已完结
FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP‐activated protein kinase–Caspase 6 signal axis
8天前
已完结
FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP‐activated protein kinase–Caspase 6 signal axis
18天前
已完结
Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease
23天前
已完结
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
26天前
已完结
Repression of the ERRγ-CYP2E1 pathway by fibroblast growth factor 4 mitigates alcoholic liver injury
1个月前
已完结
Renal ischemia/reperfusion injury: An insight on in vitro and in vivo models
1个月前
已完结
Therapeutic alpha-1-microglobulin ameliorates kidney ischemia reperfusion injury
1个月前
已关闭
Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury
1个月前
已完结
Antifibrotic potential of reserpine (alkaloid) targeting Keap1/Nrf2; oxidative stress pathway in CCl4-induced liver fibrosis
1个月前
已完结
皖公网安备34019202002308
